Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
maralixibat (LIVMARLI) (1 trial)
perflutren protein-type a microspheres (Optison) (1 trial)
Cerebral Infarction (Phase 2)
Ischemia (Phase 2)
Stroke (Phase 2)
Trials (2 total)
Trial APIs (2 total)